← Back to Search

Ultrasound Imaging

Prospective Observational for Aortic Valve Disease

N/A
Waitlist Available
Research Sponsored by Philips Clinical & Medical Affairs Global
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up procedure through 48 hours or discharge, whichever is earlier
Awards & highlights

Summary

The purpose of this observational registry is to report real-world safety and performance of VeriSight for ultrasound guided ICE imaging in percutaneous cardiac intervention procedures when used in standard clinical practice.

Eligible Conditions
  • Aortic Valve Disease
  • Aortic Valve Stenosis
  • Tricuspid Valve Disease
  • Patent Foramen Ovale
  • Atrial Septal Defect
  • Mitral Valve Disease
  • Atrial Fibrillation
  • Stroke
  • Valvular Heart Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during procedure
This trial's timeline: 3 weeks for screening, Varies for treatment, and during procedure for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Clinical Success
Device-related adverse event detection
Imaging Success
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Prospective ObservationalExperimental Treatment1 Intervention
Prospective observational subjects undergoing planned cardiac procedures utilizing image guidance

Find a Location

Who is running the clinical trial?

Philips Clinical & Medical Affairs GlobalLead Sponsor
53 Previous Clinical Trials
16,745 Total Patients Enrolled
Rashmi Ram, PhDStudy DirectorPhilips Clinical and Medical Affairs
~40 spots leftby Sep 2025